Bill > HB1680

This bill aims to prohibit prior authorization requirements for prescription drugs used to prevent HIV (Human Immunodeficiency Virus) infection across a wide range of health benefit plans in Texas. The legislation applies to numerous types of health insurance providers, including insurance companies, health maintenance organizations, group hospital service corporations, and various government health programs like Medicaid and the child health plan program. The bill specifically prohibits health benefit plan issuers from requiring enrollees to obtain prior authorization for prescription drugs prescribed to prevent HIV infection. This means that individuals seeking medications like pre-exposure prophylaxis (PrEP) would be able to access these drugs more quickly and easily. The provisions will apply to health benefit plans delivered, issued, or renewed on or after January 1, 2026, and the act itself will take effect on September 1, 2025. The law includes an exception for individual health benefit plans issued on or before March 23, 2010, that have not undergone significant changes reducing benefits or increasing costs. The bill's goal is to remove administrative barriers that might prevent people from accessing important HIV prevention medications.

Business and Industry

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB1680